This genetic study revealed that GLP-1 receptor agonists reduce weight by reducing more fat mass than muscle mass. The research findings were published in Diabetes, Obesity and Metabolism.
A research team assessed the impact of GLP-1 receptor agonist in weight loss through genetic studies, aiming to understand whether the use of these medications reduces weight due to muscle or fat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback